Bearish on MRNA ... about MRNA 11/09/09
Where will they get the 2010 expense money needed to continue? Just pulling of another financial rabbit out of the Hat, for the magician, Ceo French like last January 2009. How many more Rabbits are
update:Nov.7th-'MRNA' QUESTIONS THAT NEED TO BE ANS..about MRNA 11/07/09
1) WHERE IS THE 2010 EXPENSE MONEY NEEDED TO CONTINUE AS A COMPANY, FOR ONGOING PRE-TESTING IN VIVO PHASES, MANAGEMENTS PAYROLL, ETC.? 2) WHEN WILL MANAGEMENT START BUYING SHARES OF THE COMPANY IF N...
Bearish on MRNA ... about MRNA 10/28/09
update:Oct.28th 'MRNA' closed at $1.04. Where are the friendly research firms, their expert analysts, high target prices of $4.00 now? Besides the poor ratings, lack of interest in the stock, poor ea...
Bearish on NSTK ... about NSTK 09/20/09
now mrna, but has gone from $20.00 to $.28 cents and now rebounded a little to $1.39. The most accurate forecaster on social picks since 2007 has been jimmy T. on (nstk) MRNA. agree with his analogy.
WHAT A DIFFERENCE A WEEK CAN MAKE!11/06/09
YESTERDAY 'MRNA' CLOSED UP A WHOPPING 12 CENTS. LOGICALLY A CURRENT SHAREHOLDER BOUGHT MORE SHARE, ABOUT 13,500, BECAUSE OF ANNOUNCEMENT UPCOMING RE:EARNINGS/CONFERENCE CALL NOV.12TH.
SINCE IT HAS BEEN ALREADY ESTIMATED AT
AROUND $-.25 CENTS-$-.29 CENTS, I DO NOT UNDERSTAND THE SHAREHOLDERS MIND AT ALL.
RELATIVE TO HIS/HER MIND SET, THE STOCK PRICE WILL GIVE BACK THE GAINS FROM YESTERDAY AN...
THURSDAY,11/05 UP A PENNY ALL DAY, THEN INDIVIDUAL BUYS A...11/05/09
AFTER PURCHASE THE STOCK WENT UP $.12 CENTS. SHAREHOLDERS THROWING MORE MONEY INTO A STOCK THAT WILL HAVE A NOT TO GOOD QTLY REPORT ON NOV.12TH NEXT WEEK. AND THE COMPANY SHOULD ANNOUNCE SERIOUSLY DURING THEIR CONFERENCE CALL, WHERE THEY WILL GET THE APPROXIMATE $24 MILLION TO PAY EXPENSES IN 2010 INSTEAD OF JUST MAKING A LOSS SOUND LIKE PEACHES & CREAM WITH WORDS OF GREAT EXPECTATIONS. IN MY O...
SOON TO REACH NEXT LOWER LEVEL SUPPORT OF $.9611/04/09
NOV.4TH, MRNA IS GETTING WEAKER&WEAKER EACH DAY. THERE IS NO SUPPORT COMFORT LEVEL AS OF YET. THEREFORE, UNDER $1 DOLLAR IT GOES, BUT THIS TIME AROUND IT STAYS UNDER $1 DOLLAR UNTIL THE END OF THE YEAR.
SHAREHOLDERS WAITING AND SPEAKING OF MONKEY RESULTS, WHILE IN THE MEAN TIME THEY CONTINUE TO WATCH THE SLIDE TO NEWER LOWER LEVELS. GRASPING ONTO ANYTHING TO DISCUSS AND EVEN PREDICTING $2.85 C...
Re: Bearish on MRNA ... 11/03/09
MRNA-Beginning to touch under $1 dollar each day, as newer lower levels are forthcoming.
Management needs to start buying the stock.
And management should announce soon, where they intend to attain the monies needed for 2010 expenses, or this stock will slide to low $.90 cents range, then $.80 cent range as year end selling/frustration sets in. Lastly, they really need to reverse split this s...
NOV.12 QTLY REPORT SOON!11/02/09
ARTICLE BY ADAM FEUERSTEIN, AT THE STREET.COM
BIOTECH CALENDAR-NOVEMBER REPORTS LEFT OUT 'MRNA', HOWEVER I COMMENTED WITH MY OPINION.
http://www.thestreet.com/story/10619916/2/biotech-calendar-key-dates-for-november.html
STOCK PRICE CONTINUES DOWNWARD UNDER $1 DOLLAR.
OCT.30TH AT 3:30P.M. UNDER $1.00 LIKE I HAVE BEEN SAYING!10/30/09
MDRNA, Inc.(NasdaqGM: MRNA)
Real-Time: 0.99 0.11 (9.99%) 3:31pm ET
IF YOU READ THE MRNA MESSAGE BOARD IT SOUNDS LIKE POSTERS/SHAREHOLDERS ARE SPEAKING ABOUT A DIFFERENT STOCK ALTOGETHER. THE OTHER DAY, BECUASE OF A .04 CENTS UPTICK AND THEN .08 CENT TICK UP, THEY ALL THOUGH IT HIT BOTTOM. MY LOGIC TO THIS STOCK IS SO SIMPLE, THAT I HAVE BEEN MORE ACCURATE ABOUT IT, AND ITS DIRECTION FOR 3 YE...
Re: Bearish on MRNA ... 10/29/09
OCT.29TH 'MRNA' COMMENT & OPINION
http://www.thestreet.com/story/10618674/2/genta-melanoma-drug-study-disappoints-biobuzz.html
A REAL BIO BUZZ TO CONSIDER!
ON COURSE TO CONTINUE DOWNWARD IN STOCK PRICE,
IT IS THE MOST LOGICAL DIRECTION BEFORE YEAR END!
Re: Managements timing has been like a Black cat lately. Very Luc..10/26/09
10/26/09 'mrna' closed at $1.15. Headed back to under $1.00 again.
I have been negative since Dec. 2006
Overall the stock price since then has retreated
from $20 dollars to as low as $.28 cents.
2009 It hit $3.00 but heading south where it belongs.
I have been the most accurate on this stock since 2007.
It is an early pre-clinical stage, with no serious earnings.
The question right now i...
update:MRNA-OCTOBER 19TH10/19/09
update:MRNA (OCTOBER 19TH) RECENT ARTICLE BY JUSTIN HALL FROM SEEKINGALPHA, MY QUESTION POSED TO HIM RE:'MRNA' AND HIS RESPONSE.
http://seekingalpha.com/article/167149-on-sma...
IF YOU ARE NOT OPEN MINDED AS AN INVESTOR, YOU STAND TO BE CRUSHED
FINANCIALLY, ESPECIALLY WITH ALL THE WARNING SIGNS ALONG THE ROAD
RIGHT NOW.
MARRIED TO A STOCK IS THE SAME AS BEING AN ALCOHOLIC.
IF I HAVE BEE...
HEADING BACK UNDER $1 DOLLAR ONCE AGAIN!10/16/09
What about the Rodney Dangerfield stock 'MRNA'?
IT HAS A NEW CEO, MORE IN VIVO NEWS THAN ELVIS SANG VIVA LAS VEGAS ON STAGE, HIGH TARGET PRICES BY RESEARCHERS, AND
DEDICATED, ADDICTED SHAREHOLDERS WHO LOOK AT THE STOCK IS IF IT WERE ONE OF THEIR CHILDREN AND CAN NOT DO ANY WRONG.
NOT A STRONG STOCK, WITH HEAVY WALL STREET BACKING, NO SERIOUS EARNINGS REVENUES, AND THE STOCK NEVER MAKES ANY I...
The investor is willing to take risks to achieve high returns from portfolio. Investor's holding consists of speculative stocks that will produce massive gains or losses and/or the trading strategy is focused more on short term profits rather than long term appreciation
Avg exp holding time:
203.73 days
Age:
60's
Occupation:
SELF EMPLOYED
Location:
NEW YORK
About Me:
Research Firms, and Stock pushers are like drug dealers. All they care about are their pockets. I pre
... more
Research Firms, and Stock pushers are like drug dealers. All they care about are their pockets. I prefer to research pipelines, Growth, Return on Equity, Debt,qtly growth instead of relying on incorrect, misinforming so called GURU'S.
Data powered by FinancialContent.
All Rights Reserved.
Quotes delayed at least 20 minutes unless otherwise indicated.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.